Investors Snag ARQT Even Cheaper Than Its Secondary Stock Offering
March 25, 2024 at 13:51 PM EDT
Looking back to 26 days ago, Arcutis Biotherapeutics Inc (ARQT) priced a 15,789,474 share secondary stock offering at $9.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..